Original Research
Accepted on 11 Feb 2026
Single-Cell Profiling of PBMCs Reveals an Immune Signature of irAEs in Anti-PD-1-Treated Acral Melanoma Patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Type at least 3 characters
9,586 articles
articles
Original Research
Accepted on 11 Feb 2026
MRPS28 serves as a biomarker of diagnostic, prognostic, and immune modulation in pan-cancer and promotes breast cancer malignant phenotypes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Systematic Review
Accepted on 11 Feb 2026
Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 11 Feb 2026
Targeting MDSCs in Cancer: Emerging Immunotherapeutic and Metabolic Strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 11 Feb 2026
UNRAVELLING THE COMPLEXITY OF THE INTERACTIONS AMONG VACCIMEL, BCG AND BLOOD MONOCYTES
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 11 Feb 2026
A Combined Immune–Nutritional Score (GRIm–CONUT) as a Prognostic Indicator in Neoadjuvant-Treated Esophageal Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 11 Feb 2026
Decoding the Role of Macrophage LAP3 in Lung Cancer – Integration of Single-Cell Technologies and Machine Learning Reveals an Orchestrating Immunometabolic Circuit at the Tumor-Epithelial Interface
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 11 Feb 2026
Integrative multi-omics and machine learning reveals the spatial niche distribution and role of CYP27A1+TAMs in immunotherapy response in Non-Small Cell Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 11 Feb 2026
Integrative Pan-Cancer Analysis Reveals AARS2 as a Lactylation-Associated Biomarker and Therapeutic Target in Colon Adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Published on 11 Feb 2026
Single-cell dissection of hepatocellular carcinoma immunity: from heterogeneous subtypes to precision therapeutics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1744845
- 153 views
Original Research
Published on 11 Feb 2026
A fully human IgG1 antibody targeting MICA α1 domain inhibits interaction with NKG2D and activates immune effector functions against MICA-expressing cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1740184
- 366 views
Original Research
Published on 11 Feb 2026
Characterizing tumor microenvironment heterogeneity in EBV+ nTNKL vs ENKTL using spatial transcriptomics and MIF
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1717844
- 155 views
Original Research
Published on 11 Feb 2026
Metabolic reprogramming of glioma-associated macrophages identifies detoxification and energetic macrophages as drivers of immunosuppression and therapeutic vulnerability
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1752553
- 326 views
Mini Review
Published on 11 Feb 2026
Functional roles and mechanisms of circRNA-protein interactions in cancer progression and tumor immune regulation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1771949
- 191 views
Original Research
Published on 11 Feb 2026
An interpretable deep learning framework based on TabNet-Cox for risk stratification and prognostic assessment in hepatocellular carcinoma immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1751829
- 249 views
Review
Published on 11 Feb 2026
The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1748272
- 270 views
Case Report
Published on 11 Feb 2026
Pathological complete response in esophageal squamous cell carcinoma complicated by malignant fistula via neoadjuvant immunotherapy, chemoradiotherapy, and nutritional support: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1750544
- 218 views
Original Research
Published on 11 Feb 2026
Efficacy of chimeric antigen receptor T-cell therapy in testicular relapse of pediatric acute lymphoblastic leukemia: a multicenter retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1766494
- 289 views
Review
Published on 11 Feb 2026
NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1763843
- 257 views
Editorial
Published on 11 Feb 2026
Editorial: Role of ncRNAs in immunogenic cell death of cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1788538
- 292 views
Review
Published on 11 Feb 2026
Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1765368
- 384 views
Original Research
Accepted on 10 Feb 2026
Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 10 Feb 2026
Ferroptosis Reshapes the Tumor Immune Microenvironment: Molecular Mechanisms, Immune Regulation, and Therapeutic Synergistic Strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 10 Feb 2026
Peripheral Blood Inflammatory Ratios Predict Efficacy and Toxicity of CAR-T Cell Immunotherapy in Relapsed/Refractory Multiple Myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology